LobbyingSociety for Cardiovascular Angiography and Interventions lobbying by quarter
Society for Cardiovascular Angiography and Interventions's latest lobbying report covers Q2 2026, at $10K. The four quarters Q4 2025–Q3 2026 total $56K. Its first report covers Q4 2022; the issues it reports most are Government Issues and Health Issues.
Society for Cardiovascular Angiography and Interventions
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $56K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $36K | 1 |
| Q1 2023 | $36K | 1 |
| Q2 2023 | $36K | 1 |
| Q3 2023 | $36K | 1 |
| Q4 2023 | $36K | 1 |
| Q1 2024 | $36K | 1 |
| Q2 2024 | $36K | 1 |
| Q3 2024 | $36K | 1 |
| Q4 2024 | $36K | 1 |
| Q1 2025 | $36K | 1 |
| Q2 2025 | $36K | 1 |
| Q3 2025 | $36K | 1 |
| Q4 2025 | $36K | 1 |
| Q1 2026 | $10K | 1 |
| Q2 2026 | $10K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Government issues$123K · 13 reports
- Health issues$123K · 13 reports
- Medicare and Medicaid$123K · 13 reports
- Labor, antitrust and workplace$54K · 6 reports
- Medical research and clinical labs$45K · 5 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES13 reports
- SENATE13 reports
- Centers For Medicare and Medicaid Services (CMS)11 reports
- Health & Human Services, Dept of (HHS)5 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseSociety for Cardiovascular Angiography and Interventions | $488K | 15 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/06for Q2 | In-house | $10K |
| 04/03for Q1 | In-house | $10K |
| 01/26for Q4 2025 | In-house | $36K |
| 01/14for Q4 2025 | In-house | $36K |
| 25/10/02for Q3 2025 | In-house | $36K |
| 25/09/18for Q1 2025 | In-house | $36K |
| 25/07/08for Q2 2025 | In-house | $36K |
| 25/04/11for Q1 2025 | In-house | $36K |
| 25/01/17for Q4 2024 | In-house | $36K |
| 24/10/02for Q3 2024 | In-house | $36K |
| 24/08/05for Q2 2024 | In-house | $36K |
| 24/06/21for Q2 2024 | In-house | $36K |
| 24/06/21for Q1 2024 | In-house | $36K |
| 24/05/29for Q1 2024 | In-house | $36K |
| 24/02/21for Q4 2023 | In-house | $36K |
| 23/10/13for Q3 2023 | In-house | $36K |
| 23/08/28for Q2 2023 | In-house | $36K |
| 23/04/20for Q1 2023 | In-house | $36K |
| 23/01/18for Q4 2022 | In-house | $36K |